Capital International Investors

Position in DXCM — Dexcom Inc

CIK 1562230 Los Angeles, CA

Position in DXCM

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$44,585,632

-$256,171,718 QoQ

Shares Held

661,999

-71.7% QoQ

Ownership

0.175%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#91

of 966 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capital International Investors holds $4,237,987,174 across 3 Medical Devices names. DXCM ranks #3 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	34,654,113	$3,144,514,213
2	ZBH	Zimmer Biomet Holdings, Inc.	12,183,614	$1,048,887,329
3	DXCM	Dexcom Inc This page	661,999	$44,585,632

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$44,585,632	661,999	-71.7%	Shares	Defined	2026-08-12
2023-06-30	$300,757,350	2,340,342	+0.4%	Shares	Defined	2023-08-11
2023-03-31	$270,688,362	2,329,905	+0.1%	Shares	Defined	2023-05-15
2022-12-31	$263,705,724	2,328,733	+0.2%	Shares	Defined	2023-02-14
2022-09-30	$187,106,984	2,323,156	-2.3%	Shares	Defined	2022-11-14
2022-06-30	$177,148,866	2,376,880	+312.5%	Shares	Defined	2022-08-15
2022-03-31	$294,777,780	576,188	+32.1%	Shares	Defined	2022-05-19
2021-12-31	$234,232,087	436,227	+24.7%	Shares	Defined	2022-02-14
2021-09-30	$191,262,644	349,747	+0.0%	Shares	Defined	2021-11-15
2021-06-30	$149,319,338	349,694	-46.4%	Shares	Defined	2021-08-16
2021-03-31	$234,322,998	652,002	+0.0%	Shares	Defined	2021-05-14
2020-12-31	$241,017,510	651,892	+271.7%	Shares	Defined	2021-02-12
2020-09-30	$72,291,538	175,367	+5.6%	Shares	Defined	2020-11-13
2020-06-30	$67,323,561	166,067	+12.5%	Shares	Defined	2020-08-14
2020-03-31	$39,735,366	147,567	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.